Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Biological Variation, Individual
Costs of Care for Operative and Nonoperative Management of Emergency General Surgery Conditions.
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia.
Therapy, Soft Tissue
The risk of secondary leukemias following autologous stem cell transplantation.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The risk of secondary leukemias following autologous stem cell transplantation.
The risk of secondary leukemias following autologous stem cell transplantation. Leuk Res. 1999 Mar; 23(3):281-2.
View in:
PubMed
subject areas
Hematopoietic Stem Cell Transplantation
Humans
Leukemia
Neoplasms, Second Primary
Risk
Transplantation, Autologous
authors with profiles
Michael Bishop